Company / Capital Expenditures
Surgery Partners, Inc. Capital Expenditures History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$90.4M
FY2024
5-year range
$42.9M / $90.4M
FY2020-FY2024
Trend
+1.8%
vs FY2023
Sector context
#64 of 151
Health Care
What the data says
At $90M, Surgery Partners, Inc.'s capital expenditures ranks #64 of 151 in the Health Care sector. Capital Expenditures has increased for 4 consecutive years, from $43M in FY2020 to $90M in FY2024.
Based on SEC 10-K filings.
$90M in FY2024 with a 5-year CAGR of +4.2%.
Improved from $81M to $90M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +16.2%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
#64 of 151 in Health CareTop 42% of 151This company $90.4M Sector average $271.7M
▼
-66.7% below sector average
Key checks
Key Insights
- Surgery Partners, Inc.'s capital expenditures has grown for 4 consecutive years.
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2024, capital expenditures increased 1.8% year-over-year.
- Ranks #64 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.31 (distress zone, below 1.8 threshold)
- Negative profit margin: -14.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $90.4M | +1.8% |
| FY2023 | $88.8M | +10.2% |
| FY2022 | $80.6M | +39.9% |
| FY2021 | $57.6M | +34.3% |
| FY2020 | $42.9M | -41.7% |
| FY2019 | $73.6M | +84.9% |
| FY2018 | $39.8M | +111.7% |
| FY2017 | $18.8M | -51.9% |
| FY2016 | $39.1M | +17.0% |
| FY2015 | $33.4M | +332.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026